ERAD Therapeutics' Unattributed Round

ERAD Therapeutics raised a round of funding on November 09, 2015.

ERAD Therapeutics technology employs an entirely new approach to treat diseases that are caused by single amino acid changes in cell proteins. These proteins result in a disease state not because they…

Articles about ERAD Therapeutics' Unattributed Round: